ZNF385A

zinc finger protein 385A

Basic information

Region (hg38): 12:54369133-54391298

Previous symbols: [ "ZNF385" ]

Links

ENSG00000161642 ∙ NCBI:25946 ∙ OMIM:609124 ∙ HGNC:17521 ∙ Uniprot:Q96PM9 ∙ AlphaFold ∙ GenCC ∙ jax ∙ Sfari ∙ GnomAD ∙ Pubmed ∙ ClinVar

Phenotypes

GenCC

Source: genCC

• Tourette syndrome (No Known Disease Relationship), mode of inheritance: Unknown

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ZNF385A gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ZNF385A gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type	Pathogenic	Likely pathogenic	VUS	Likely benign	Benign	Sum
synonymous					1	1
missense			20	2		22
nonsense						0
start loss						0
frameshift						0
inframe indel						0
splice donor/acceptor (+/-2bp)						0
splice region					1	1
non coding						0
Total	0	0	20	2	1

Variants in ZNF385A

This is a list of pathogenic ClinVar variants found in the ZNF385A region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position	Type	Phenotype	Significance	ClinVar
12-54370452-G-T		not specified	Uncertain significance (Feb 07, 2025)
12-54370461-A-G		not specified	Uncertain significance (Jul 14, 2023)
12-54370628-C-T		not specified	Uncertain significance (May 02, 2024)
12-54370691-C-T		not specified	Uncertain significance (Mar 07, 2025)
12-54370728-G-A			Benign (Jul 16, 2018)
12-54371015-G-A		not specified	Uncertain significance (Oct 12, 2021)
12-54371541-C-G		not specified	Uncertain significance (Oct 16, 2024)
12-54371542-G-A		not specified	Uncertain significance (Jan 02, 2024)
12-54371569-T-C		not specified	Uncertain significance (Mar 26, 2024)
12-54371574-C-G		not specified	Uncertain significance (Dec 05, 2022)
12-54371604-C-T		not specified	Uncertain significance (Aug 22, 2022)
12-54371637-G-A		not specified	Uncertain significance (May 03, 2023)
12-54371688-G-A		not specified	Uncertain significance (Sep 22, 2023)
12-54371702-A-G			Benign (Feb 25, 2018)
12-54371710-T-C		not specified	Uncertain significance (Sep 30, 2024)
12-54373984-G-A		not specified	Uncertain significance (Dec 28, 2023)
12-54374014-C-T		not specified	Uncertain significance (Mar 29, 2022)
12-54374036-G-A		not specified	Uncertain significance (Dec 09, 2024)
12-54374045-C-T		not specified	Likely benign (Jan 10, 2023)
12-54374093-G-C		not specified	Uncertain significance (Sep 25, 2024)
12-54374095-C-T		not specified	Uncertain significance (Jan 09, 2024)
12-54375885-C-T		not specified	Likely benign (Aug 04, 2021)
12-54375917-A-G		not specified	Uncertain significance (Aug 12, 2021)
12-54384560-G-T		not specified	Uncertain significance (Dec 30, 2024)
12-54391240-A-T		not specified	Uncertain significance (May 13, 2024)

GnomAD

Source: gnomAD

Gene	Type	Bio Type	Transcript	Coding Exons	Length
ZNF385A	protein_coding	protein_coding	ENST00000338010	8	22166

pLI Probability LOF Intolerant	pRec Probability LOF Recessive	Individuals with no LOFs	Individuals with Homozygous LOFs	Individuals with Heterozygous LOFs	Defined	p
0.280	0.719	125733	0	5	125738	0.0000199

	Z-Score	Observed	Expected	Observed/Expected	Mutation Rate	Total Possible in Transcript
Missense	1.69	139	208	0.670	0.0000113	2404
Missense in Polyphen		50	94.022	0.53179		1147
Synonymous	1.04	74	86.3	0.858	0.00000458	862
Loss of Function	2.87	4	16.7	0.240	0.00000117	169

LoF frequencies by population

Ethnicity	Sum of pLOFs	p
African & African-American	0.00	0.00
Ashkenazi Jewish	0.00	0.00
East Asian	0.00	0.00
Finnish	0.00	0.00
European (Non-Finnish)	0.0000367	0.0000352
Middle Eastern	0.00	0.00
South Asian	0.00	0.00
Other	0.000163	0.000163

dbNSFP

Source: dbNSFP

• Function: FUNCTION: RNA-binding protein that affects the localization and the translation of a subset of mRNA. May play a role in adipogenesis through binding to the 3'-UTR of CEBPA mRNA and regulation of its translation. Targets ITPR1 mRNA to dendrites in Purkinje cells, and may regulate its activity-dependent translation. With ELAVL1, binds the 3'-UTR of p53/TP53 mRNAs to control their nuclear export induced by CDKN2A. Hence, may regulate p53/TP53 expression and mediate in part the CDKN2A anti- proliferative activity. May also bind CCNB1 mRNA. Alternatively, may also regulate p53/TP53 activity through direct protein-protein interaction. Interacts with p53/TP53 and promotes cell-cycle arrest over apoptosis enhancing preferentially the DNA binding and transactivation of p53/TP53 on cell-cycle arrest target genes over proapoptotic target genes. May also regulate the ubiquitination and stability of CDKN1A promoting DNA damage-induced cell cycle arrest. Also plays a role in megakaryocytes differentiation. {ECO:0000269|PubMed:17719541}.
• Pathway: Regulation of TP53 Activity through Association with Co-factors;Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription;Transcriptional activation of cell cycle inhibitor p21 ;Transcriptional activation of p53 responsive genes ;p53-Dependent G1 DNA Damage Response;p53-Dependent G1/S DNA damage checkpoint;G1/S DNA Damage Checkpoints;Cell Cycle Checkpoints;TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest;TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest;TP53 Regulates Transcription of Cell Cycle Genes;Regulation of TP53 Activity through Association with Co-factors;Regulation of TP53 Activity;Transcriptional Regulation by TP53;Direct p53 effectors;Cell Cycle (Consensus)

Recessive Scores

• pRec: 0.112

Intolerance Scores

• loftool: 0.328
• rvis_EVS: -0.54
• rvis_percentile_EVS: 20.26

Haploinsufficiency Scores

• pHI: 0.239
• hipred: Y
• hipred_score: 0.617
• ghis: 0.607

Essentials

• essential_gene_CRISPR: N
• essential_gene_CRISPR2: N
• essential_gene_gene_trap: N
• gene_indispensability_pred: N
• gene_indispensability_score: 0.323

Gene Damage Prediction

	All	Recessive	Dominant
Mendelian	Medium	Medium	Medium
Primary Immunodeficiency	Medium	Medium	Medium
Cancer	Medium	Medium	Medium

Mouse Genome Informatics

• Gene name: Zfp385a
• Phenotype: digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype; growth/size/body region phenotype

Gene ontology

• Biological process: regulation of transcription by RNA polymerase II;apoptotic process;cellular response to DNA damage stimulus;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;hemostasis;learning or memory;locomotory behavior;mRNA localization resulting in posttranscriptional regulation of gene expression;platelet formation;megakaryocyte development;positive regulation of fat cell differentiation;platelet alpha granule organization;regulation of signal transduction by p53 class mediator;positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;regulation of cytoplasmic translation
• Cellular component: nuclear chromatin;nucleoplasm;nucleolus;cytoplasm;dendrite;neuronal cell body
• Molecular function: DNA-binding transcription factor activity, RNA polymerase II-specific;p53 binding;DNA binding;RNA binding;mRNA 3'-UTR binding;zinc ion binding